Abstract 207: Cardiovascular Outcomes of Sodium-glucose Co-transporter 2 Inhibitors: A Meta-analysis

Ahmad N. Lone,Muhammad Rashid Khan,Muhammad U. Khan,Mohammad Sadik Khan,Safi U. Khan

Abstract 207: Cardiovascular Outcomes of Sodium-glucose Co-transporter 2 Inhibitors: A Meta-analysis

2020

Ahmad N. Lone
Muhammad Rashid Khan
Muhammad U. Khan
Mohammad Sadik Khan
Safi U. Khan

Background: Concerns exist that mortality benefit might vary across different drugs (canagliflozin, empagliflozin, dapagliflozin) belonging to sodium-glucose cotransporter-2 (SGLT2) inhibitors. Met...

Keywords:

cardiovascular outcomes
Transporter
Meta-analysis
Sodium
Physical therapy
Medicine
Bioinformatics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations